Who Can Get Molnupiravir, the COVID-19 Drug? We check!

Molnupiravir is a drug produced by the American company Merck in cooperation with the biotechnology company Ridgeback Biotherapeutics. It works by inhibiting the multiplication of the coronavirus. By the end of 2021, Merck was to produce tablets sufficient for 10 million treatment cycles, many of these deliveries have been purchased by individual countries and the first batches are reaching them. It turns out that also to Poland.

URGENT There are the first Polish victims of Omikron! They are two men. What connects them?

Who Can Get Molnupiravir, the COVID-19 Drug? We check!

“Experts recommend, in the current epidemiological situation, administering the drug Molnupiravir to people infected with SARS-Cov-2 with impaired immune response immediately after the diagnosis of the infection, but not later than 5 days after the appearance of symptoms” explains Katarzyna Kubicka-Żach from the Communications Office of the Ministry of Health And he adds that a drug can be administered in people receiving anti-cancer therapy, transplant patients taking immunosuppressants, advanced or untreated HIV infection, chronic dialysis for renal failure.

The official also adds that the first batches of the product are already distributed by the Government Strategic Reserves Agency to medical entities that submitted a demand.

About Peter Wilson

In love with technology, with an eye towards smartphones, he does not disdain any activity linked to the Nerd world. TV series, movies, manga, anime, and comics (Marvel addicted) are the order of the day.

Check Also

Minor changes in the menstrual cycle following vaccination pass quickly

You can read more about health on the main website of Gazeta.pl “Studies on the …

Leave a Reply

Your email address will not be published.